Talk:Evidence-based assessment/Attention deficit hyperactivity disorder (assessment portfolio)
This is the discussion page for discussing improvements to the Evidence-based assessment/Attention deficit hyperactivity disorder (assessment portfolio) article. | |||
---|---|---|---|
|
|
ADHD in Adults
editThis is a topic that definitely needs attention. Per conversations with John Rush, there is a high level decision about whether adult versus youth assessment should be split into separate pages.
Even with that up for discussion, there is a need to gather resources for adult assessment. Here's a start of a few to consider:
ASRS v1.1 was developed by Kessler and co. with the copyright assigned to the World Health Organization. Here's a link to the page for it at Harvard. The open questions with it include:
- Is there a collateral/other report version?
- Are there better norms than the 2005 estimate on that site (which was a weighted estimate using a clinical sample)?
- Any information about sensitivity to treatment effects?
- Has anyone ROCed it against the NCS-R or other structured diagnostic interviews?
The CADDRA website is a Canadian nonprofit organization that has a set of several interesting measures on it, including two by M.D. Weiss that were new to me (the second being a very detailed functioning one), as well as some prototype clinical transfer forms that could be interesting models. Open questions here:
- Has Weiss published any research on these?
- If not, any data?
- Any interest in sharing?
- What do expert clinicians think of the medication form, the transfer form, etc?
The CHADD website lists several tools, including a DSM-5 version of the 6 item ASRS v 1.1 validated in the Ustan et al. (2017) JAMA Psychiatry paper.[3]
The Kooij et al. 2019[4] open access article recommends the DIVA 2 as an interview -- we should add it.
Severity interviews for ADHD
editMeasure | Format (Reporter) | Age Range | Administration/
Completion Time |
Where to Access |
---|---|---|---|---|
Youth | ||||
Adults | ||||
Note: L = Less than adequate; A = Adequate; G = Good; E = Excellent; U = Unavailable; NA = Not applicable [5]
ICD-11
editShould the Diagnosis section also include ICD-11 criteria for Hyperkinetic disorder? —ShelleyAdams (discuss • contribs) 14:09, 5 February 2017 (UTC)
DBD
editPelham wrote a DBD scale that covered DSM-IV symptoms of ADHD, ODD, CD; Waschbush says that it is public domain; worth looking at systematically across the three disorders. If valid, could be worth adding to all three, and also building Wp Page, Wv Page, Qualtrics....
Worth comparing PCARES battery to TOC, chapter recommendations, portfolio list. Eyoungstrom (discuss • contribs) 17:45, 5 October 2018 (UTC)
Summer 2022 Audit
editPreparation phase
editDiagnostic Criteria of ADHD in youth
editBase rates of youth ADHD in different populations and clinical settings
editdo we need a column for 'best recommended for' if none of them have a check? Hope Holloway (discuss • contribs) 14:32, 13 June 2022 (UTC)
Prediction phase
editPsychometric properties of screening instruments for youth ADHD
editScreening and diagnostic instruments for attention deficit hyperactivity disorder
editdo we have the rest of the information to fill out this table? Hope Holloway (discuss • contribs) 14:33, 13 June 2022 (UTC)
Conners 3, Vanderbilt, BASC = top 3
Likelihood ratios and AUCs of screening measures for (insert portfolio name)
editneed to change this name to include portfolio name Hope Holloway (discuss • contribs) 14:24, 13 June 2022 (UTC) do we need a download column on the table if it's empty? Hope Holloway (discuss • contribs) 14:43, 13 June 2022 (UTC)
Interpreting ADHD screening measure scores
editPrescription phase
editGold standard diagnostic interviews
editlink broken to PDFs Hope Holloway (discuss • contribs) 14:24, 13 June 2022 (UTC)
Recommended diagnostic interviews for ADHD
editTaking out adult section and will look in A Guide to Assessments That Work by Hunsley & Mash
Severity interviews for ADHD
editneed to change depression instrument placeholders Hope Holloway (discuss • contribs) 14:24, 13 June 2022 (UTC) need to remove extra rows on the tables Hope Holloway (discuss • contribs) 14:24, 13 June 2022 (UTC)
Process phase
editProcess measures
editOutcome and severity measures
editsee here link just leads to table below Hope Holloway (discuss • contribs) 14:24, 13 June 2022 (UTC)
Treatment
editlast link is external- should this be noted or changed? Hope Holloway (discuss • contribs) 01:48, 14 June 2022 (UTC)
External Links
editlast four links lead to FIU broken page Hope Holloway (discuss • contribs) 14:24, 13 June 2022 (UTC)
References
edit- ↑ Kessler, Ronald C.; Adler, Lenard; Ames, Minnie; Demler, Olga; Faraone, Steve; Hiripi, Eva; Howes, Mary J.; Jin, Robert et al. (2005-02). "The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population". Psychological Medicine 35 (2): 245–256. doi:10.1017/S0033291704002892. ISSN 0033-2917. https://www.cambridge.org/core/product/identifier/S0033291704002892/type/journal_article.
- ↑ Richarte, Vanesa; Corrales, Montserrat; Pozuelo, Marian; Serra-Pla, Juanfran; Ibáñez, Pol; Calvo, Eva; Corominas, Margarida; Bosch, Rosa et al. (2017-10). "Validación al español de la ADHD Rating Scale (ADHD-RS) en adultos: relevancia de los subtipos clínicos". Revista de Psiquiatría y Salud Mental 10 (4): 185–191. doi:10.1016/j.rpsm.2017.06.003. https://linkinghub.elsevier.com/retrieve/pii/S1888989117300897.
- ↑ Ustun, Berk; Adler, Lenard A.; Rudin, Cynthia; Faraone, Stephen V.; Spencer, Thomas J.; Berglund, Patricia; Gruber, Michael J.; Kessler, Ronald C. (2017-05-01). "The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5". JAMA Psychiatry 74 (5): 520. doi:10.1001/jamapsychiatry.2017.0298. ISSN 2168-622X. PMID 28384801. PMC PMC5470397. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2616166.
- ↑ Kooij, J.J.S.; Bijlenga, D.; Salerno, L.; Jaeschke, R.; Bitter, I.; Balázs, J.; Thome, J.; Dom, G. et al. (2019). "Updated European Consensus Statement on diagnosis and treatment of adult ADHD". European Psychiatry 56 (1): 14–34. doi:10.1016/j.eurpsy.2018.11.001. ISSN 0924-9338. https://www.cambridge.org/core/product/identifier/S092493380000910X/type/journal_article.
- ↑ "Evidence-based assessment/Reliability - Wikiversity". en.wikiversity.org. Retrieved 2020-11-13.